KIF3A and urinary bladder cancer: To explore the mechanism underlying KIF3A‐mediated clinical characteristics and prognosis of bladder cancer, we used shRNAs that specifically knock down KIF3A in two types of bladder cancer cell lines, namely, T24 and 5637.